Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
123,850,680
-
Total 13F shares
-
124,539,664
-
Share change
-
+9,639,745
-
Total reported value
-
$2,855,453,478
-
Put/Call ratio
-
304%
-
Price per share
-
$22.94
-
Number of holders
-
264
-
Value change
-
+$192,800,636
-
Number of buys
-
133
-
Number of sells
-
126
Institutional Holders of Guardant Health, Inc. - Common Stock (GH) as of Q3 2024
As of 30 Sep 2024,
Guardant Health, Inc. - Common Stock (GH) was held by
264 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
124,539,664 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP, CADIAN CAPITAL MANAGEMENT, LP, Deep Track Capital, LP, BAILLIE GIFFORD & CO, Capital International Investors, EVENTIDE ASSET MANAGEMENT, LLC, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, and BRAIDWELL LP.
This page lists
264
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.